Serina Therapeutics, Inc. (NYSEAMERICAN:SER – Get Free Report)’s stock price shot up 6.8% on Tuesday . The company traded as high as $2.10 and last traded at $2.04. Approximately 141,701 shares were traded during mid-day trading, an increase of 1% from the average daily volume of 139,816 shares. The stock had previously closed at $1.91.
Serina Therapeutics Stock Performance
The company has a current ratio of 4.18, a quick ratio of 4.18 and a debt-to-equity ratio of 0.24. The stock’s 50 day moving average price is $1.86.
Serina Therapeutics (NYSEAMERICAN:SER – Get Free Report) last announced its quarterly earnings results on Thursday, May 14th. The company reported ($0.58) EPS for the quarter.
About Serina Therapeutics
Serina Therapeutics, Inc, a biotechnology company, develops drugs to treat neurological diseases and pain. Its lead product candidate is SER 252, a POZ conjugate for the treatment of Parkinson’s disease. The company also develops SER 227 for long-acting pain relief; SER 214 to treat Parkinson’s disease; and SER 228 for the treatment of epilepsy. In addition, it develops POZ technology in lipid nanoparticle delivered ribonucleic acid vaccines for infectious diseases. Serina Therapeutics, Inc was founded in 2006 and is based in Huntsville, Alabama.
Featured Articles
- Five stocks we like better than Serina Therapeutics
- Credo Technologies Accelerates AI—Its Stock Price Will Follow
- Qualcomm Goes All-In: The $10B Bet to Crush NVIDIA
- Jabil Just Gave Investors a Stronger Reason to Buy the Dip
- CarMax In Reverse? Why You Should Buy Now Before the Big Catalysts Emerge
Receive News & Ratings for Serina Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Serina Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
